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Abstract. 
 
In vertebrate embryos, signaling via the
 
b
 
-catenin protein is known to play an essential role in 
the induction of the dorsal axis. In its signaling capacity, 
 
b
 
-catenin acts directly to affect target gene transcrip-
tion, in concert with transcription factors of the TCF/
LEF family. We have developed a cell-free in vitro as-
say for 
 
b
 
-catenin signaling activity that utilizes tran-
scriptionally active nuclei and cytoplasm from cleavage-
blocked 
 
Xenopus laevis
 
 embryos. Under these assay 
conditions, we demonstrate that either addition of
 
b
 
-catenin protein or upstream activation of the 
 
b
 
-cate-
nin signaling pathway can induce the expression of de-
velopmentally relevant target genes. Addition of exoge-
nous 
 
b
 
-catenin protein induced expression of 
 
Siamois
 
, 
 
XTwin
 
, 
 
Xnr3
 
, and 
 
Cerberus
 
 mRNAs in a protein syn-
thesis independent manner, whereas a panel of other 
Spemann organizer-speciﬁc genes did not respond to
 
b
 
-catenin. Lithium induction of the 
 
b
 
-catenin signaling 
pathway, which is thought to cause 
 
b
 
-catenin accumula-
tion by inhibiting its proteasome-dependent degrada-
tion, caused increased expression of 
 
Siamois
 
 in a pro-
tein synthesis independent fashion. This result suggests 
that 
 
b
 
-catenin derived from a preexisting pool can be 
activated to signal, and that accumulation of this acti-
vated form does not require ongoing synthesis. Further-
more, activation of the signaling pathway with lithium 
did not detectably alter cytoplasmic 
 
b
 
-catenin levels 
and was insensitive to inhibition of the proteasome-
dependent degradation pathway. Taken together, these 
results suggest that activation of 
 
b
 
-catenin signaling by 
lithium in this system may occur through a distinct acti-
vation mechanism that does not require modulation of 
levels through regulation of proteasomal degradation.
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 a key intermediate in the Wnt signaling pathway,
 
b
 
-catenin and its homologues are known to play
important roles in numerous developmental pro-
cesses, including segmentation in 
 
Drosophila melanogaster
 
(Peifer et al., 1991), cell fate determinations in 
 
Caenorhab-
ditis elegans
 
 (Thorpe et al., 1997; Giarre et al., 1998), and
dorsal axis formation in vertebrates (McCrea et al., 1993;
Heasman et al., 1994; Funayama et al., 1995). In addition
to its role in developmental events, the loss of control of
 
b
 
-catenin signaling has been shown to be an essential step
in the progression of cancer in certain differentiated tis-
sues (for review, see Gumbiner, 1997; Bullions and Le-
vine, 1998).
As a central component of the cadherin adhesion com-
plex, 
 
b
 
-catenin is expressed widely in the cells of verte-
brates. However, this cadherin-bound pool of 
 
b
 
-catenin is
not thought to directly participate in signaling. Rather, a
pool of free 
 
b
 
-catenin (not bound to cadherins) enters the
nucleus (Fagotto et al., 1998) and, through direct interac-
tion with transcription factors of the TCF/LEF family, af-
fects transcriptional activation at target gene promoters
(Behrens et al., 1996; Huber et al., 1996; Molenaar et al.,
1996). Therefore, modulation of the levels or activity of
these noncadherin bound pool(s) of 
 
b
 
-catenin is likely to
be crucial for effective control of the signaling pathway.
Maintenance of low levels of cytoplasmic 
 
b
 
-catenin is
brought about by ubiquitin-dependent degradation (Ab-
erle et al., 1997; Orford et al., 1997; Jiang and Struhl, 1998;
Marikawa and Elinson, 1998; for review, see Maniatis,
1999). In cell culture systems, ubiquitin-dependent degra-
 
dation of 
 
b
 
-catenin is facilitated by the interaction of
 
b
 
-catenin with a number of proteins, including axin/conduc-
tin (Zeng et al., 1997; Behrens et al., 1998; Hart et al., 1998;
Ikeda et al., 1998; Itoh et al., 1998; Kishida et al., 1998; Na-
kamura et al., 1998; Yamamoto et al., 1998), the adenoma-
tous polyposis coli (APC)
 
1
 
 protein (Rubinfeld et al., 1993;
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Munemitsu et al., 1995), and Slimb/
 
b
 
-TRCP (Marikawa
and Elinson, 1998; Winston et al., 1999). In these systems,
phosphorylation of NH
 
2
 
-terminal serine/threonine resi-
dues of 
 
b
 
-catenin, directly or indirectly, by glycogen syn-
thase kinase 3 (GSK-3; Yost et al., 1996) is thought to
result in 
 
b
 
-TRCP binding and subsequent delivery of tar-
geted 
 
b
 
-catenin to the proteasomal degradation pathway.
Upstream activation of the Wnt signaling pathway is
thought to result in the inactivation of GSK-3, and gives
rise to a concomitant increase in the levels and/or signaling
activity of 
 
b
 
-catenin. While increased levels of 
 
b
 
-catenin
have been correlated with activation of the signaling path-
way, other modes of regulation may exist (Young et al.,
1998). For example, it is possible that regulation could oc-
cur at the level of nuclear import (Fagotto et al., 1998) or
transcriptional activity at target gene promoters.
A number of target genes of 
 
b
 
-catenin signaling have
been identified, both in developmental and pathological
cellular contexts. In 
 
Xenopus laevis
 
, 
 
b
 
-catenin/TCF respon-
sive elements have been described in the promoters 
 
Siam-
ois
 
 (Brannon et al., 1997), 
 
XTwin
 
 (Laurent et al., 1997),
and 
 
Xnr3
 
 (McKendry et al., 1997). In 
 
Drosophila
 
, 
 
En-
grailed
 
 and 
 
Ultrabithorax
 
 have been suggested to be tran-
scriptionally responsive to 
 
b
 
-catenin/TCF (Riese et al.,
1997; van de Wetering et al., 1997). In colon cancer cells,
c-myc and cyclin D1 have been identified as targets of the
 
b
 
-catenin signaling pathway (He et al., 1998; Shtutman et
al., 1999; Tetsu and McCormick, 1999). It is likely that
 
b
 
-catenin may target distinct sets of response genes, de-
pending on the availability of regulatory cofactors or,
alternatively, tissue-specific chromatin-based control of
gene expression.
During early development in 
 
Xenopus
 
, cortical rotation
leads to the activation of 
 
b
 
-catenin signaling in the dorsal
region of blastula stage embryos and, subsequently, to the
induction of the dorsal axis (for review, see Moon and
Kimelman, 1998). A number of studies have shown that
 
b
 
-catenin signaling is required for activities ascribed to the
early dorsalizing inductive region known as the Nieuw-
koop center (Heasman et al., 1994; Guger and Gumbiner,
1995; Wylie et al., 1996). While secreted signals from the
Nieuwkoop center are known to be sufficient for the in-
duction of the Spemann organizer in overlying mesoderm
(Nieuwkoop, 1977; Wylie et al., 1996), recent data suggest
that 
 
b
 
-catenin signaling may also be able to induce Spe-
mann organizer-specific genes in a cell autonomous man-
ner (Darras et al., 1997; Laurent et al., 1997). In these
studies, it is suggested that differential interpretation of
 
b
 
-catenin signaling along the animal/vegetal axis directs
the formation of the Spemann organizer, even in the ab-
sence of Nieuwkoop-derived secreted signals (for review,
see Kodjabachian and Lemaire, 1998).
We have developed a cell-free assay system that utilizes
cytoplasm and nuclei from cleavage-blocked embryos.
This assay allows for detection of changes in gene expres-
sion upon addition of purified 
 
b
 
-catenin protein or by ad-
dition of lithium, a GSK-3 inhibitor, and for the exclusion
of indirect inductions that occur through cell–cell interac-
tions or through intervening synthesis steps. We show that
signaling induced by exogenous 
 
b
 
-catenin in our cell-free
assay system recapitulates direct inductive events that oc-
cur in whole embryos. This assay system has many advan-
 
tages over whole embryo studies with regard to analysis of
direct inductive events in the early embryo, and is shown
to be useful for analysis of the of 
 
b
 
-catenin signaling and
regulation.
 
Materials and Methods
 
Preparation of Baculovirus-expressed
 
b
 
-Catenin Protein
 
b
 
-Catenin protein containing an NH
 
2
 
-terminal 6-His tag was expressed in
Sf9 cells using a baculoviral expression system, as described previously
(Fagotto et al., 1998). Expressed protein was purified on NTA affinity
resin (Qiagen).
 
Preparation of Cleavage-blocked (Coenocytic) Embryos
 
Eggs were obtained from HCG-treated 
 
Xenopus 
 
females (Nasco), and
were fertilized by standard procedures. Cleavage blockade was achieved
by a low-speed centrifugation procedure described by Newport and
Kirschner (1982), and is described briefly below. 45 min after fertilization,
embryos (in 0.1
 
3
 
 MMR) were layered onto a 50% Ficoll cushion (in 0.1
 
3
 
MMR) and centrifuged at 500 
 
g
 
 for 10 min at 15
 
8
 
C. Noncentrifuged sibling
embryos were maintained as a reference for developmental stage. After
centrifugation, cleavage blocked (coenocytic), multinucleate embryos and
nonblocked sibling embryos were incubated at 18
 
8
 
C. Several hours after
centrifugation, coenocytic embryos that showed clear evidence of at-
tempted cleavage (evidenced by furrows in the lipid cap) were selected for
use in the 
 
b
 
-catenin signaling assay.
 
Cell-free Assay for 
 
b
 
-Catenin Signaling
 
A schematic diagram of the cell-free assay used in these studies is shown
in Fig. 1. When sibling control embryos reached stage 8 (unless otherwise
noted), 20 coenocytic embryos were placed in 1.8-ml centrifuge tubes (one
tube per experimental condition). To minimize dilution of cytoplasm upon
disruption, 0.5 ml Versilube (Andpak-EMA) was layered over the em-
bryos, followed by a brief spin at 300 
 
g
 
, which effectively separates em-
bryos from aqueous buffer. The overlying separated buffer droplet and
Versilube oil was aspirated gently and, as completely as possible, from the
embryos. Before crushing embryos, a number of components were added
Figure 1. A cell-free assay system for b-catenin signaling. 40 min
after fertilization, cleavage blockade of Xenopus embryos is
brought about by a gentle spin over a Ficoll cushion (500 g), and
then are incubated until nonblocked sibling embryos reach stage
8. b-Catenin, lithium, or other components are then introduced
into embryonic cytoplasm by a 16,000 g spin crush, followed by
an incubation to allow for induction of target genes in underlying
nuclei. 
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over the intact coenocytic embryos. Proteinase inhibitors (PMSF 
 
1
 
 pro-
tease inhibitor cocktail II) were added to give the following cytoplasmic
concentrations: 1 mM PMSF, 2 
 
m
 
g/ml leupeptin, 4 
 
m
 
g/ml aprotinin, 10 
 
m
 
g/
ml antipain, 50 
 
m
 
g/ml benzamidine, 10 
 
m
 
g/ml STI, 100 
 
m
 
g/ml iodoacet-
amide. To provide for regeneration of cytoplasmic ATP stores, an energy
mix was added to give cytoplasmic concentrations of 7.5 mM creatine phos-
phate, 1.0 mM ATP, and 50 
 
m
 
M magnesium chloride. To block protein syn-
thesis, cycloheximide was added to give a cytoplasmic concentration of 5
 
m
 
g/ml. Indicated amounts of 
 
b
 
-catenin protein or lithium were then added
to the embryos, followed by a 7-min spin crush centrifugation at 16,000 
 
g
 
(maximum centrifugal force in Eppendorf microcentrifuge) at 4–8
 
8
 
C. After
spin crush, tubes were incubated at 22
 
8
 
C for 1.5 h, which is sufficient for
maximal induction and expression of target genes, as indicated by semi-
quantitative reverse transcriptase (RT)-PCR. Increasing incubation time
beyond this point was found to have detrimental effects on reproducibility.
Proteasome inhibitors ALLN and MG132 (both purchased from Sigma
Chemical Co.; stocks were dissolved in ethanol at 25 mM) were included
under certain experimental conditions in the cell-free assay. In these
cases, the proteasome inhibitors were diluted 1:1,000 to give a cytoplasmic
concentration of 
 
z
 
25 
 
m
 
M.
 
Preparation of RNA and RT-PCR
 
Total RNA was isolated from crushed embryos using Ultraspec RNA iso-
lation reagent (Biotecx). RNA from 20 embryos was resuspended in 400
 
m
 
l of DEPC ddH
 
2
 
O (to give RNA concentrations of 
 
z
 
300 
 
m
 
g/ml).
Detection of gene expression was carried out using standard RT-PCR
procedures (Wilson and Melton, 1994) using 
 
32
 
P-labeled dCTP and auto-
radiographic detection. Sequences of primer pairs used to detect the ex-
pression of various early 
 
Xenopus
 
 genes were as follows: 
 
EF-1
 
a
 
 upstream,
5
 
9
 
 CAGATTGGTGCTGGATATGC 3
 
9
 
; 
 
EF-1
 
a
 
 downstream, 5
 
9 
 
ACTGC-
CTTGATGACTCCTAG 3
 
9
 
; 
 
Siamois
 
 upstream, 5
 
9
 
 CGCGGATCCATG-
GCCTATGAGGCTGAAATGGAG 3
 
9
 
; 
 
Siamois
 
 downstream, 5
 
9
 
 GCT-
CTAGAGAAGTCAGTTTGGGTAGGGCT 3
 
9
 
; 
 
XTwin
 
 upstream, 5
 
9
CATGACTTGTTGACTCTGA 39; XTwin downstream, 59 TGGCGTA-
GATCCCAGTAGA 39;  Xnr3 upstream, 59 ATGGCATTTCTGAAC-
CTG 39; Xnr3 downstream, 59 TCTACTGTCACACTGTGA 39; Cerberus
upstream, 59 ATGTTACTAAATGTACTCAG 39;  Cerberus down-
stream, 59 CTTGGCACCAGGCTTTTC 39; Noggin upstream, 59 ATG-
GATCATTCCCAGTGC 39;  Noggin downstream, 59 TCTGTGCTTT-
TTGCTCTG 39;  Forkhead upstream, 59ATGCTAAATAGAGTC-
AAG39;  Forkhead downstream, 59 GTAAGAGTATGGGGGCTT 39;
Xlim upstream, 59 ATGGTTCACTGTGCTGGA 39; Xlim downstream,
59 GGGGTCACTGCCTGTTAC 39;  Follistatin upstream, 59 ATGT-
TAAATGAAAGGATCCAG 39;  Follistatin downstream, 59 TCTTC-
CCAGGGCCACAGTC 39; Xotx2 upstream, 59 ATGATGTCTTATCT-
CAAGC 39; Xotx2 downstream, 59 TGGCCTCCATTCTGCTGC 39.
Protein Extractions, Western Blotting, and Metabolic 
Labeling of Proteins
Following standard electrophoretic and transfer procedures, Xenopus
b-catenin was detected in Western blots using a polyclonal rabbit anti-
body directed against the NH2-terminal region of the protein. Proteins
from crushed embryos were extracted with 1% NP-40 extraction buffer.
For ConA precipitations of cadherin-bound b-catenin, 1/10 vol of a 1:1
slurry of ConA-Sepharose beads were added to protein extracts, and al-
lowed to incubate 4 h overnight at 48C. The efficacy of the ConA precipi-
tations was indicated by the loss of detectable C-cadherin in Western
blots. To test the effectiveness of cycloheximide inhibition of protein syn-
thesis, 7 mCi of 35 S methionine (ProMix cell labeling mix; Nycomed Am-
ersham, Inc., Pharmacia Biotech) was added to stage 8 coenocytic em-
bryos before the spin crush step in the cell-free assay procedure. After 1.5 h,
these samples were extracted in 1% NP-40, soluble material was separated
electrophoretically, and visualized using fluorography. Immunoprecipita-
tion of b-catenin was carried out using a rabbit polyclonal antibody di-
rected against the NH2 terminus of the protein, followed by incubation
with protein A–Sepharose beads.
Results
Cleavage Blockade Inhibits Normal Induction of
b-Catenin Target Genes
In these studies, our goal was the development of a cell-
free assay for analysis of the b-catenin signaling pathway.
Such a system would require both transcriptionally active
nuclei and cytoplasm that is competent to transmit a b-cate-
nin dependent signal. Such a system would also require
that, in the absence of added b-catenin (or alternative acti-
vators of the pathway), potential target genes of b-catenin
signaling be either off or expressed at a low, basal level.
Cleavage blockade of embryos would be expected to
preclude any intercellular communications that are re-
quired for specific activation of dorsal genes, and would
result in a single, freely diffusing cytoplasm. The induction
of a number of genes known to be downstream targets in
the b-catenin signaling pathway during early development
is significantly reduced in coenocytic embryos, compared
with normal embryos (Fig. 2), although zygotic transcrip-
tion occurs normally in these embryos (Newport and Kirsch-
ner, 1982; Nelson and Gumbiner, 1998). Therefore, the
b-catenin mediated signaling events that induce target
gene expression in normal embryos appear to be signifi-
cantly reduced or disrupted in cleavage blocked embryos.
A Cell-free Signaling Assay Recapitulates
b-Catenin–dependent Inductive Events that Occur in 
the Embryo
We developed a novel cell-free assay (see Materials and
Methods and Fig. 1) that used endogenous nuclei and cy-
toplasm from cleavage-blocked embryos. Induction of the
expression of Siamois, a known target gene of b-catenin
signaling (Brannon et al., 1997; Nelson and Gumbiner,
1998), was responsive to added b-catenin protein in a
dose-dependent manner (Fig. 3 A). The levels of exoge-
nous b-catenin required for these inductions was relatively
low, compared with total endogenous b-catenin, but
roughly similar to the levels of the nonglycoprotein-associ-
ated (presumably cytosolic) pools of b-catenin (Fig. 3 A).
The addition of b-catenin into the crushed embryo sys-
tem induced the expression of a number of genes previ-
ously described as direct targets of b-catenin signaling.
b-catenin induced expression of Siamois, Xtwn, and Xnr3
(Fig. 3 B). These inductions demonstrate that all required
steps for b-catenin signaling, including nuclear localiza-
tion, interaction with TCF, and activation of transcription
at target sites can all occur in this disrupted assay system.
b-Catenin Specifically Induces Siamois, Xnr3, XTwin, 
and Cerberus in a Protein Synthesis
Independent Manner
To further characterize the b-catenin induced signaling
Figure 2. Cleavage blockade
reduces the normal expres-
sion of dorsal marker genes.
Activation of b-catenin tar-
get genes and EF-1a (loading
control) was assessed by RT-
PCR in whole developing
embryos (WE) and in coeno-
cytic embryos (Coen.) at
stage 7 (pre-MBT) and stage
9 (post-MBT).The Journal of Cell Biology, Volume 147, 1999 370
events that occur in the cell-free assay system, we carried
out a comprehensive analysis of various early marker
genes, focusing on those expressed in the Nieuwkoop cen-
ter or Spemann organizer. In addition to inducing Siamois,
Xnr3, and XTwin, b-catenin resulted in a weak, but repro-
ducible, induction in the expression of Cerberus, a novel
secreted factor expressed in the anterior endoderm that
gives rise to head structures (Bouwmeester et al., 1996;
Fig. 4). All of the genes induced by b-catenin were in-
duced in a protein synthesis independent manner, suggest-
ing these inductive events are direct. The ability of b-cate-
nin to directly target Cerberus is a novel observation, as
previous studies have suggested a requirement for inter-
vening synthesis of Xtwn or Siamois protein. Goosecoid,
which has been shown to respond to b-catenin signaling
through intervening expression of XTwin and Siamois, is
not induced by b-catenin protein under conditions where
Siamois, Xnr3, and XTwin are induced. A number of other
dorsal marker genes were evaluated (Fig. 4), none of
which were induced by b-catenin, either in the presence or
absence of protein synthesis.
Lithium Induces Downstream Target Genes in the
Cell-free Assay without New Synthesis of b-Catenin
It is known that lithium has dorsalizing effects on Xenopus
embryos (Aoshima et al., 1986; Kao and Elinson, 1988).
While lithium is thought to inhibit the phosphoinositol cy-
cle in Xenopus (Busa and Gimlich, 1989), it is likely that
the dorsalizing activity of lithium occurs through activa-
tion of the Wnt pathway by direct inhibition of GSK-3
(Stambolic et al., 1996; Hedgepeth et al., 1997). In the pre-
vailing turnover model for Wnt signaling, inactivation of
GSK-3 by lithium results in blockage of the ongoing ubiq-
uitin-dependent degradation of cytosolic b-catenin as a re-
sult of its dephosphorylation. This stabilization of b-cate-
nin is thought to lead to its accumulation in the cytoplasm,
which in turn allows for activation of downstream dorsal
target genes. In the turnover model, continuing synthesis
of b-catenin would provide the source of protein that
would allow for enhanced cytosolic levels.
In the cell-free assay, Siamois was induced by the addi-
tion of lithium (Fig. 5 A). The inductive effect of lithium
was dependent on b-catenin, as sequestration of b-catenin
by addition of purified C-cadherin intracellular domain
protein was inhibitory (Fig. 5 B). In contrast, an equivalent
amount of the juxtamembrane portion of the intracellular
Figure 3. Target gene induc-
tion and b-catenin dose re-
sponsiveness in the cell-free
assay system. A, Increasing
amounts of b-catenin protein
(as indicated) were added to
20 crushed embryos under
standard cell-free assay con-
ditions. RT-PCR (upper
panel) analysis of Siamois ex-
pression revealed a dose-
dependent induction. West-
ern blot analysis of total
lysate and ConA-Sepharose–
treated (glycoprotein de-
pleted) lysate was carried out
using antibodies to the NH2-
terminal region of b-catenin
(lower two panels). Endogenous and free b-catenin show different electrophoretic mobility, due to the presence of a 63 His tag on the
exogenous protein. Incubation of extracts with ConA-Sepharose effectively depleted C-cadherin below detectable levels (data not
shown). B, In addition to Siamois, addition of b-catenin (1.5 mg/20 embryo condition) induces expression of XTwin and Xnr3 mRNA,
as demonstrated by RT-PCR.
Figure 4. b-catenin induces a subset of dorsal marker genes in a
protein synthesis independent manner. The standard cell-free as-
say (6 b-catenin protein) was carried out with and without 5 mg/
ml (cytoplasmic concentration) cycloheximide, as indicated. This
dose of cycloheximide effectively inhibits protein translation in
crushed embryos, as is evidenced by 35S incorporation (right).
RT-PCR analysis (left) revealed that b-catenin induced Siamois,
XTwin, Xnr3, and Cerberus in the presence or absence of protein
synthesis. Other genes that were analyzed were not induced by
b-catenin in any condition. The lane marked WE St. 9 represents
an RT-PCR reaction conducted on cDNA derived from normal
embryos at stage 9 (at the termination of the assay).Nelson and Gumbiner A Cell-Free Assay System for b-Catenin Signaling 371
domain of C-cadherin, which does not bind b-catenin, was
not inhibitory (Fig. 5 B). Therefore, as in normal embryos,
lithium can activate an endogenous signaling pool of
b-catenin in the cell-free assay system. Induction of Siam-
ois by lithium occurred in the absence of protein synthesis
(Fig. 5 A), suggesting that the b-catenin responsible for
this signaling event is derived from preexisting pools, not
from newly translated protein. This lack of a requirement
for ongoing protein synthesis was surprising in the context
of the current turnover model for b-catenin–dependent
signaling, in which increased levels of cytosolic b-catenin
are responsible for activation of the signaling pathway.
It is thought that proteasome-dependent degradation of
b-catenin in the absence of upstream signal serves to block
accumulation of cytosolic pools. In other systems, the sig-
naling activity of lithium (Stambolic et al., 1996) and pro-
teasomal inhibitors (Easwaran et al., 1999) have been cor-
related with increased levels of b-catenin protein. In our
in vitro assay system, there was no detectable increase
in b-catenin levels (total or nonglycoprotein-associated) in
response to activating levels of added lithium (Fig. 6, A
and B). However, it should be noted that the lithium in-
duction of Siamois (approximately twofold) is relatively
weak, compared with maximal induction brought about by
b-catenin protein (greater than tenfold). Based on our ti-
tration of b-catenin protein (see Fig. 3), a response similar
to that seen with lithium would require an approximate
twofold increase over levels of cytoplasmic b-catenin.
Thus, while we detect no such changes in levels in our ex-
periments, it may be difficult to detect minor changes in
b-catenin protein levels.
The addition of proteasome inhibitors ALLN or MG132,
like lithium, did not detectably alter b-catenin levels in our
assay system (data not shown). In addition, inclusion of
proteasome inhibitors did not lead to an overall increase
in polyubiquitinated proteins, as assessed by Western blots
using antiubiquitin antibodies (data not shown), suggest-
ing that proteasomal degradation machinery may not be
strongly active in our assay system. Furthermore, protea-
some inhibitors did not activate Siamois, nor did they have
any effect on lithium-induced activation of Siamois (Fig.
7). Taken together, these results suggest that activation of
b-catenin signaling by lithium likely involves mechanisms
other than modulation of levels through regulation of pro-
teasomal degradation.
Figure 5. Lithium induction
of Siamois mRNA expres-
sion. A, Lithium was intro-
duced at a final cytoplasmic
concentration of 16 mM in
crushed embryo cytoplasm
under standard assay condi-
tions. RT-PCR analysis of
gene expression reveals that
this concentration of lithium
induces Siamois in the pres-
ence or absence of protein
synthesis. EF-1a serves as a
loading control. Protein syn-
thesis was blocked by inclu-
sion of cycloheximide in the
crushed embryo cytoplasm
(final cytoplasmic concentra-
tion, 5 mg/ml), as is demon-
strated by the loss of meta-
bolically labeled protein
bands in the right panel. B,
RT-PCR analysis of Siamois
expression reveals that addi-
tion of 2 ml of 1 mg/ml recom-
binant C-cadherin intracellu-
lar domain protein (CT)
effectively blocks induction by exogenous b-catenin (left) or lithium (right), whereas equivalent amounts of the membrane-proximal
portion (P) of the intracellular domain of C-cadherin (lacking catenin binding sites) has no effect (right and left).
Figure 6. Lithium does not
affect the levels of endoge-
nous or exogenous b-cate-
nin. A, An anti–b-catenin
probed Western blot shows
levels of endogenous total or
non-ConA precipitable (post-
ConA)  b-catenin, with or
without lithium induction. B,
Addition of lithium did not
affect the stability of small,
nonsignaling amounts of added
recombinant  b-catenin. 7.5
ng of b-catenin protein was
added to assay tubes in the
presence or absence of added
lithium. Total 1% NP-40 ly-
sate was analyzed by Western blot using antibodies against
b-catenin. Exogenous and endogenous b-catenin are distin-
guished by their electrophoretic mobility, as marked.The Journal of Cell Biology, Volume 147, 1999 372
Discussion
We have developed a novel cell-free assay system that re-
capitulates b-catenin–mediated signaling events occurring
in the Xenopus embryo. From a developmental stand-
point, this assay system has general utility in identification
of transcriptional targets of early developmental signaling.
In addition, this assay provides a potentially useful new
tool for molecular analysis of the complex regulatory
mechanisms that control b-catenin signaling.
This cell-free assay system offers several clear advan-
tages over cleaving embryos as a system for identification
of direct transcriptional target genes. First, in the cell-free
assay system, signaling occurs in a single, uniform cyto-
plasm in the absence of any intercellular communication,
which could lead to secondary inductions. Secondly, as sig-
naling components in the assay are introduced at a time
when the embryo is able to respond transcriptionally, the
assay allows for a precise timing of inductive events. This
is in contrast with RNA injection into cleaving embryos,
which requires injection before the onset of zygotic tran-
scription. Because of these advantages, the cell-free assay
holds promise not just for studies of b-catenin signaling,
but may also be adapted for other signaling pathways in
the early embryo.
To confirm the efficacy of our assay system, we first
evaluated the ability of b-catenin to induce expected tar-
get genes. Siamois, XTwin, and Xnr3 have all been re-
ported to be direct targets of b-catenin signaling, and were
all found to be specifically induced in the cell-free assay
system. Thus, all required events for induction of target
genes, including nuclear localization and interaction with
TCF family members, can occur in the cell-free system.
In addition to known target genes, the assay allowed us
to identify Cerberus as an additional direct target of
b-catenin signaling. Previous reports have shown that acti-
vation of the b-catenin signaling pathway results in induc-
tion of Cerberus. These whole embryo injection studies
suggested that Cerberus may be induced through the secon-
dary inductive effects of the Siamois gene product, rather
than direct activation by b-catenin (Darras et al., 1997). It
is clear in our assay, however, that induction of Siamois or
Twin proteins is not required for the Cerberus response to
b-catenin, as the Cerberus induction is protein synthesis
independent. There are two possible explanations for
these differing results. First, as there is some basal level of
expression of Siamois and Twin in our assay, it is possible
that b-catenin/TCF and Siamois and/or Twin protein co-
operate at the Cerberus promoter. Alternatively, in the
embryo, it is possible that Siamois may activate b-catenin
signaling, which then directly activates Cerberus. Indeed,
there is evidence that Siamois induces itself by a feedback
mechanism (Fan et al., 1998) and, given the strong direct
inductive effects of b-catenin on Siamois, it is not un-
reasonable to consider that this may occur indirectly via
b-catenin.
While we observed a number of direct inductions of dor-
sal genes, we found no evidence for secondary inductions
(that is, inductions that require intervening cell-cell com-
munications or protein synthesis) under the conditions
used for the assay. Particularly notable, in this regard, is
the absence of Goosecoid induction. Goosecoid has been
reported to involve wnt/b-catenin responsive elements, as
well as activin/TGFb responsive elements (Crease et al.,
1998). Wnt/b-catenin responsiveness has been attributed
to direct binding of Xtwn (and likely Siamois) at the
Goosecoid promoter (Laurent et al., 1997). Since XTwin
mRNA expression is strongly induced in the cell-free as-
say system, the absence of Goosecoid induction is of inter-
est. While we cannot rule out technical reasons for the ab-
sence of Goosecoid induction (i.e., insufficient time for
secondary inductions or inappropriate cytoplasmic envi-
ronment), it is possible that induction at the Goosecoid
promoter normally requires additional input that in nor-
mal embryos would derive from a Nieuwkoop center sig-
naling activity. In addition, none of the other early dorsal
marker genes we evaluated were induced by b-catenin, ei-
ther in the presence or absence of protein synthesis. This
would suggest that intervening cell–cell communication or
synthesis steps that are required for activation of these
genes do not occur in the cell-free assay system.
In addition to identification of target genes, we also used
the cell-free assay to examine the source of endogenous
signaling pools of b-catenin after addition of lithium.
While lithium is known to exert effects on phosphoinositol
metabolism in a number of systems, more recent evidence
suggests that the dorsalizing effect of lithium on early Xe-
nopus embryos occurs primarily through lithium’s inhibi-
tory effects on GSK-3 (Stambolic et al., 1996; Hedgepeth
et al., 1997). According to the current turnover model for
regulation of b-catenin signaling (Peifer, 1996), the down-
regulation of GSK-3 activity results in the stabilization of
free cytoplasmic pools of b-catenin in dorsal cytoplasm,
and subsequent activation of dorsal genes. In Drosophila,
activation of the Wnt pathway can lead to a net increase in
b-catenin in cells, presumably through accumulation of
newly synthesized protein (Peifer et al., 1994).
The addition of lithium in our assay system results in an
induction of Siamois expression. This induction requires
the participation of free pools of b-catenin, as is indicated
by the sensitivity of this response to added C-cadherin in-
tracellular domain protein. These observations indicate
Figure 7. Effects of proteasome inhibitors on Siamois induction.
Samples treated with lithium and/or the proteasome inhibitors
ALLN or MG132 were evaluated by RT-PCR using Siamois and
EF1a primer sets. Proteasome inhibitors (25 mM), introduced
upon crushing the embryos, did not induce Siamois and did not
affect lithium induction of Siamois.Nelson and Gumbiner A Cell-Free Assay System for b-Catenin Signaling 373
that, in the cell-free assay system, lithium is capable of
generating an endogenous signaling pool of b-catenin. In
addition, the insensitivity of the inductive response to pro-
tein synthesis inhibition suggests that accumulation of
newly synthesized b-catenin is not required for b-catenin
signaling activity. Rather, it appears that actively signaling
b-catenin protein can be wholly derived from a preexist-
ing, nonsignaling pool (for instance, pools associated with
cadherins or cytoplasmic molecules, such as axin and
APC), with no requirement for newly synthesized protein.
In these studies, lithium activates endogenous b-catenin
signaling in the absence of an input of protein from new
synthesis and without detectable increases in cytoplasmic
levels of b-catenin. Furthermore, while in some systems
proteasomal inhibitors have been shown to activate
b-catenin signaling (Easwaran et al., 1999), proteasomal
inhibitors in our assay had no effect on levels of b-catenin
and did not influence the activation of the signaling path-
way with lithium. Thus, signaling in this assay does not ap-
pear to rely on the accumulation of cytoplasmic b-catenin
brought about by regulation of the proteasomal degrada-
tion pathway. Rather, these results could be explained by
an alteration in the intrinsic signaling activity of cytoplas-
mic b-catenin. Indeed, recent studies in our laboratory
have indicated that putative GSK-3 phosphorylation sites
in the NH2 terminus of b-catenin may regulate its signaling
activity independent of levels (Gumbiner, B.M., manu-
script submitted for publication), even in the whole em-
bryo. These findings suggest the possibility of the exist-
ence of an alternative mechanism of activation that may
act independently or in parallel with regulation of cyto-
plasmic levels of b-catenin.
By allowing direct access to the cytoplasm, the described
cell-free assay makes possible a wide range of potential
biochemical manipulations in addition to the applications
presented here. For example, conditions of this assay
could be adapted to allow for testing the effects of immu-
nodepletion of associated components of the b-catenin
signaling pathway. Also, the assay is well-suited to allow
for assessing the signaling activity of exogenously derived
cytoplasm, or for testing cytoplasmic fractions or various
purified components for regulatory activities.
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